Timely Visibility into Channel Revenue and Profit Trends

Medical Device manufacturers that utilize distribution channels often lack full control and visibility into what can be a significant percentage of their revenue. Risks include suboptimal pricing and sub-par rebates compliance.  For manufacturers that rely heavily on direct business, it can be difficult for Pricing and Contracting teams to uncover key contract performance drivers to guide contract negotiations at the account level.

Model N Channel Strategy helps manufacturers increase distribution strategy effectiveness, maintain price consistency in the market, and impede price erosion by improving visibility into direct and channel sales and pricing. The comprehensive solution:

    • Aggregates available data and monitors channel business

    • Aggregates opportunity, order, contract, and contract compliance data across direct business

    • Provides a consistent and repeatable analytics framework with relevant metrics and visualizations to make proactive, data-driven business decisions

Services


    • Training

      Best practices insight generation, Channel ImpACT

With regulatory changes imposed by the Deficit Reduction Act looming, Procter & Gamble and Model N worked together to successfully implement the Government Pricing application within an aggressive nine-month timeframe. No matter what obstacle or challenge we presented, Model N responded with a workable solution.

Ron Brandt, Director of Contracting
Procter & Gamble Pharma